DR. ANITA PRAKASH VIN-PARIKH MD
Prescription History 1609005461
Ophthalmology - Glaucoma Specialist in Raleigh, NC
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ANITA PRAKASH VIN-PARIKH MD, an active Glaucoma Specialist specialist practicing in Raleigh, NC. Our medical registry currently tracks 20 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,163 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 1,069 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NC PrescribersVs. NC Avg |
|---|---|---|---|
| Latanoprost | 1,069 | $26.51 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 1,069 Medicare prescriptions for Latanoprost, about 7 times the volume of the typical North Carolina prescriber of this medication (152). Medicare paid an average of $26.51 per fill, versus $22.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 2,528.2 30-Day Fills standardized to 30-day supplies 74,901 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 419 | $15.66▼ below NC avg | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 419 Medicare prescriptions for Brimonidine Tartrate, about 6.2 times the volume of the typical North Carolina prescriber of this medication (68). Medicare paid an average of $15.66 per fill, versus $44.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 919.8 30-Day Fills standardized to 30-day supplies 27,244 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 383 | $24.34▼ below NC avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 383 Medicare prescriptions for Dorzolamide-Timolol, about 4.2 times the volume of the typical North Carolina prescriber of this medication (91). Medicare paid an average of $24.34 per fill, versus $30.91 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 863 30-Day Fills standardized to 30-day supplies 25,830 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 348 | $15.75▼ below NC avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 348 Medicare prescriptions for Timolol Maleate, about 4.8 times the volume of the typical North Carolina prescriber of this medication (72). Medicare paid an average of $15.75 per fill, versus $21.45 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 856.9 30-Day Fills standardized to 30-day supplies 25,557 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 167 | $27.79▼ below NC avg | ▲ More than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 167 Medicare prescriptions for Dorzolamide Hcl, about 3 times the volume of the typical North Carolina prescriber of this medication (55). Medicare paid an average of $27.79 per fill, versus $30.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 382.9 30-Day Fills standardized to 30-day supplies 11,481 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 161 | $606.17 | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 161 Medicare prescriptions for Lumigan, about 2.7 times the volume of the typical North Carolina prescriber of this medication (60). Medicare paid an average of $606.17 per fill, versus $435.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 352.6 30-Day Fills standardized to 30-day supplies 10,347 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 98 | $390.94 | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 98 Medicare prescriptions for Combigan, about 2.5 times the volume of the typical North Carolina prescriber of this medication (40). Medicare paid an average of $390.94 per fill, versus $365.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 154 30-Day Fills standardized to 30-day supplies 4,360 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 86 | $574.87 | ▲ More than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 86 Medicare prescriptions for Rhopressa, about 1.9 times the volume of the typical North Carolina prescriber of this medication (45). Medicare paid an average of $574.87 per fill, versus $465.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 145.1 30-Day Fills standardized to 30-day supplies 4,222 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 78 | $864.37 | ▲ More than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 78 Medicare prescriptions for Rocklatan, about 1.8 times the volume of the typical North Carolina prescriber of this medication (44). Medicare paid an average of $864.37 per fill, versus $484.65 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 163.7 30-Day Fills standardized to 30-day supplies 4,820 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 69 | $279.08 | ▲ More than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 69 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 2.7 times the volume of the typical North Carolina prescriber of this medication (26). Medicare paid an average of $279.08 per fill, versus $276.06 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 122.8 30-Day Fills standardized to 30-day supplies 3,501 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 64 | $32.94▼ below NC avg | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 64 Medicare prescriptions for Prednisolone Acetate, about half the volume of the typical North Carolina prescriber of this medication (109). Medicare paid an average of $32.94 per fill, versus $48.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 101.3 30-Day Fills standardized to 30-day supplies 2,818 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 50 | $442.62 | ▲ More than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 50 Medicare prescriptions for Alphagan P, about 1.4 times the volume of the typical North Carolina prescriber of this medication (37). Medicare paid an average of $442.62 per fill, versus $370.24 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 92.9 30-Day Fills standardized to 30-day supplies 2,659 Days of Medication total across all patients in 2023 | |||
| Difluprednate | 30 | $142.33▼ below NC avg | ≈ Typical |
About Difluprednate: This medication is used to treat swelling and pain after eye surgery. Show more ▾ It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 30 Medicare prescriptions for Difluprednate, about the same volume as the typical North Carolina prescriber of this medication (32). Medicare paid an average of $142.33 per fill, versus $161.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 36.1 30-Day Fills standardized to 30-day supplies 991 Days of Medication total across all patients in 2023 | |||
| MoxifloxacinMoxifloxacin Hcl | 30 | $28.94▼ below NC avg | ▼ Less than typical |
About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾ A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. In 2023, this provider wrote 30 Medicare prescriptions for Moxifloxacin, about a third of the volume of the typical North Carolina prescriber of this medication (94). Medicare paid an average of $28.94 per fill, versus $38.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 32 30-Day Fills standardized to 30-day supplies 548 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 25 | $1,659.13 | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 25 Medicare prescriptions for Restasis, about half the volume of the typical North Carolina prescriber of this medication (44). Medicare paid an average of $1,659.13 per fill, versus $1,145.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 61 30-Day Fills standardized to 30-day supplies 1,830 Days of Medication total across all patients in 2023 | |||
| VyzultaLatanoprostene Bunod | 24 | $552.80 | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. In 2023, this provider wrote 24 Medicare prescriptions for Vyzulta, about 73% of the volume of the typical North Carolina prescriber of this medication (33). Medicare paid an average of $552.80 per fill, versus $430.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,135 Days of Medication total across all patients in 2023 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 20 | $344.23 | ▼ Less than typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2023, this provider wrote 20 Medicare prescriptions for Simbrinza, about 63% of the volume of the typical North Carolina prescriber of this medication (32). Medicare paid an average of $344.23 per fill, versus $255.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39.7 30-Day Fills standardized to 30-day supplies 1,182 Days of Medication total across all patients in 2023 | |||
| Brinzolamide | 15 | $319.91▼ below NC avg | ▼ Less than typical |
About Brinzolamide: Brinzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 15 Medicare prescriptions for Brinzolamide, about half the volume of the typical North Carolina prescriber of this medication (28). Medicare paid an average of $319.91 per fill, versus $337.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| Acetazolamide | 15 | $46.96▼ below NC avg | ▼ Less than typical |
About Acetazolamide: Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. Show more ▾ This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures). One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) In 2023, this provider wrote 15 Medicare prescriptions for Acetazolamide, about 68% of the volume of the typical North Carolina prescriber of this medication (22). Medicare paid an average of $46.96 per fill, versus $80.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Acetazolamide ErAcetazolamide | 12 | $70.65▼ below NC avg | ▼ Less than typical |
About Acetazolamide Er: Acetazolamide is used to prevent and reduce the symptoms of altitude sickness. Show more ▾ This medication can decrease headache, tiredness, nausea, dizziness, and shortness of breath that can occur when you climb quickly to high altitudes (generally above 10,000 feet/3,048 meters). It is particularly useful in situations when you cannot make a slow ascent. The best ways to prevent altitude sickness are climbing slowly, stopping for 24 hours during the climb to allow the body to adjust to the new height, and taking it easy the first 1 to 2 days. This medication is also used with other medications to treat high pressure inside the eye due to certain types of glaucoma. Acetazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye. It is also used to decrease a buildup of body fluids (edema) caused by heart failure or certain medications. Acetazolamide can work less well over time, so it is usually used only for a short period. It has also been used with other medications to treat certain types of seizures (petit mal and unlocalized seizures). One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) In 2023, this provider wrote 12 Medicare prescriptions for Acetazolamide Er, about 71% of the volume of the typical North Carolina prescriber of this medication (17). Medicare paid an average of $70.65 per fill, versus $95.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 14 30-Day Fills standardized to 30-day supplies 405 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. ANITA PRAKASH VIN-PARIKH MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Glaucoma Specialist prescribing approach at this Raleigh, NC practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NC prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
